Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Currenc Group Inc. - Ordinary Shares (OP:CURR)

N/A UNCHANGED
Last Price Updated: 3:04 PM EDT, Aug 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1150
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Avenir Wellness Solutions Reports Third Quarter 2023 Results
Via ACCESSWIRE
Marijuana Stock Movers For August 8, 2023
 
Via Benzinga

Performance

More News

Read More
Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
Via ACCESSWIRE
Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year Over Year Revenue Increases and Continued High Gross Margins
Via ACCESSWIRE
Avenir Wellness Solutions Update to Stockholders
Via ACCESSWIRE
Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
Via ACCESSWIRE
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
Via Benzinga
Avenir Wellness Solutions Stock Trading Higher On Q1 Revenue Growth Of 15.1% YoY
Via Benzinga
Cannabis Stock Movers For July 21, 2023
Via Benzinga
Avenir Wellness Letter to Stockholders
Via ACCESSWIRE
Cannabis Stock Movers For August 3, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From July 18, 2023
Via Benzinga
Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use
Via ACCESSWIRE
CURE Pharmaceutical Unveils Exciting New Brand Identity with Name Change to Avenir Wellness Solutions, Inc.
Via ACCESSWIRE
CURE Pharmaceutical Letter to Shareholders
Via ACCESSWIRE
Marijuana Stock Movers For August 2, 2023
Via Benzinga
Marijuana Stock Movers For July 17, 2023
Via Benzinga
Marijuana Stock Movers For July 31, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From July 14, 2023
Via Benzinga
Wide Marketing and Shipments Commenced for New Patent Pending DNA Complex Skin Care Used by Top Movie and TV Star Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
Most Powerful Anti-Aging Product Lines with Patent Pending DNA Complex; Endorsed by Oscars Night 2023 Presenter Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
Avenir Wellness Solutions, Inc. Gains High Profile Exposure on theSkimm Social Media Platform With 7 Million Followers and Launches New Website in Support of Corporate Rebranding
Via ACCESSWIRE
Nicole Kidman Endorsed Wellness and Beauty Products; On-Track for Accelerated Sales Growth with Company Rebranded as Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street
Via ACCESSWIRE
Anti-Aging Wellness Products; Q3 Revenues Surge; $20 Million non-dilutive IP Asset Sale: Cure Pharmaceutical Inc. (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property

Frequently Asked Questions

Is Currenc Group Inc. - Ordinary Shares publicly traded?
Yes, Currenc Group Inc. - Ordinary Shares is publicly traded.
What exchange does Currenc Group Inc. - Ordinary Shares trade on?
Currenc Group Inc. - Ordinary Shares trades on the OTC Traded
What is the ticker symbol for Currenc Group Inc. - Ordinary Shares?
The ticker symbol for Currenc Group Inc. - Ordinary Shares is CURR on the OTC Traded
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.